{"id":"NCT00431132","sponsor":"Novo Nordisk A/S","briefTitle":"Endometrial Safety of a Low Dose of Vagifem速 in Postmenopausal Women With Atrophic Vaginitis","officialTitle":"A 12 Month, Open-label, Multi-center Trial to Investigate the Endometrial Safety of Vagifem Low Dose (10ug 17beta-estradiol Vaginal Tablet) in Postmenopausal Women With Atrophic Vaginitis Symptoms","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2007-02-05","resultsPosted":"2011-04-07","lastUpdate":"2017-03-15"},"enrollment":336,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Menopause","Postmenopausal Vaginal Atrophy"],"interventions":[{"type":"DRUG","name":"estradiol, 10 mcg","otherNames":[]}],"arms":[{"label":"Vagifem速 10 mcg","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Europe. The purpose of this study is to evaluate endometrial safety of intravaginal estradiol (Vagifem速) in healthy postmenopausal women having atropic vaginitis.","primaryOutcome":{"measure":"Endometrial Hyperplasia Based on Histological Assessment of Endometrial Biopsies","timeFrame":"Week 52","effectByArm":[{"arm":"Vagifem速 10 mcg","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"45 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":42,"countries":["Czechia","Denmark","Finland","France","Hungary","Norway","Sweden"]},"refs":{"pmids":["20859151","18978105"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":336},"commonTop":["Nasopharyngitis"]}}